These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 3697989
1. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents. Huland E, Arndt R, Huland H. Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989 [Abstract] [Full Text] [Related]
2. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)]. Li C, Yan RP, Yuan GH, Feng YG, Wang JS, Gao X, Huang YS, Zhou JB, Xie SS. Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782 [Abstract] [Full Text] [Related]
3. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients]. Zhang H, Zhao Z, Sun H. Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163 [Abstract] [Full Text] [Related]
4. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer. Dhawan D, Ramos-Vara JA, Stewart JC, Zheng R, Knapp DW. Urol Oncol; 2009 Sep; 27(3):284-92. PubMed ID: 18562222 [Abstract] [Full Text] [Related]
5. Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissues. Ben-Aïssa H, Paulie S, Koho H, Biberfeld P, Hansson Y, Braesch-Andersen S, Lagerkvist M, Lundblad ML, Gustafson H, Perlmann P. Anticancer Res; 1986 Sep; 6(2):165-70. PubMed ID: 2423013 [Abstract] [Full Text] [Related]
6. A new in vivo model to study invasion and metastasis of human bladder carcinoma. Ahlering TE, Dubeau L, Jones PA. Cancer Res; 1987 Dec 15; 47(24 Pt 1):6660-5. PubMed ID: 3677100 [Abstract] [Full Text] [Related]
7. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells. Masuko T, Abe J, Yagita H, Hashimoto Y. Jpn J Cancer Res; 1985 May 15; 76(5):386-94. PubMed ID: 3924712 [Abstract] [Full Text] [Related]
8. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas. Hellström I, Hellström KE, Rollins N, Lee VK, Hudkins KL, Nepom GT. Cancer Res; 1985 May 15; 45(5):2210-8. PubMed ID: 3986770 [Abstract] [Full Text] [Related]
9. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium. Ben-Aïssa H, Paulie S, Gustafsson B, Håkansson L, Lagerkvist M, Gustafson H, Ahlstrand C, Perlmann P. Anticancer Res; 1988 May 15; 8(3):443-9. PubMed ID: 3389746 [Abstract] [Full Text] [Related]
10. Xenogenic transplantation of human bladder- and renal-cell carcinoma into NMRI mice treated with cyclosporin A and into NMRI nu/nu mice. Introduction of a new experimental cancer model. Otto U, Huland H, Klöppel G, Baisch H. Urol Int; 1987 May 15; 42(1):1-5. PubMed ID: 3590401 [Abstract] [Full Text] [Related]
11. [Characterization of monoclonal antibody (BIU-H) directed against bladder cancer and its pathologic feature]. Guo Y. Zhonghua Yi Xue Za Zhi; 1992 Apr 15; 72(4):213-5, 254. PubMed ID: 1327448 [Abstract] [Full Text] [Related]
12. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Reid LM, Leav I, Kwan PW, Russell P, Merk FB. Cancer Res; 1984 Oct 15; 44(10):4560-73. PubMed ID: 6467211 [Abstract] [Full Text] [Related]
13. [Whole-body fluorescent imaging of the growth and metastasis of GFP-expressing bladder tumors]. Wu YD, Tan WL, Xie Y, Yu ZC, Zhao GZ. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr 15; 26(4):436-40. PubMed ID: 16624746 [Abstract] [Full Text] [Related]
14. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma]. Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ. Arch Esp Urol; 2002 Apr 15; 55(1):41-9. PubMed ID: 11957750 [Abstract] [Full Text] [Related]
15. Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder. Milella M, Jacobelli J, Cavallo F, Guarini A, Velotti F, Frati L, Foà R, Forni G, Santoni A. Br J Cancer; 1999 Feb 15; 79(5-6):770-9. PubMed ID: 10070868 [Abstract] [Full Text] [Related]
16. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Metzgar RS, Gaillard MT, Levine SJ, Tuck FL, Bossen EH, Borowitz MJ. Cancer Res; 1982 Feb 15; 42(2):601-8. PubMed ID: 7034925 [Abstract] [Full Text] [Related]
17. [Analysis of bladder cancer-associated antigens and their application to diagnosis]. Masuko T, Hashimoto Y. Gan To Kagaku Ryoho; 1987 Jun 15; 14(6 Pt 2):2191-7. PubMed ID: 3606146 [Abstract] [Full Text] [Related]
18. Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice. Kyriazis AA, Kyriazis AP, McCombs WB, Peterson WD. Cancer Res; 1984 Sep 15; 44(9):3997-4005. PubMed ID: 6744315 [Abstract] [Full Text] [Related]
19. [Contribution of monoclonal antibodies within the framework of urothelial tumors of the bladder]. Chopin DK. Pathol Biol (Paris); 1988 Apr 15; 36(4):301-8. PubMed ID: 3287299 [Abstract] [Full Text] [Related]
20. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II). Mizutani Y, Yoshida O, Bonavida B. J Urol; 1998 Aug 15; 160(2):561-70. PubMed ID: 9679929 [Abstract] [Full Text] [Related] Page: [Next] [New Search]